Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions

Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.

George N. Thalmann, Ploutarchos Anezinis, Shi Chang et al. · PubMed · 1994 · 739 citations

Urology, Oncology, Lncap Model +14

Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals

Jian-Su Shao, Su‐Li Cheng, Joyce M. Pingsterhaus et al. · Journal of Clinical Investigation · 2005 · 438 citations · Full text

The Runx2 Osteogenic Transcription Factor Regulates Matrix Metalloproteinase 9 in Bone Metastatic Cancer Cells and Controls Cell Invasion

Jitesh Pratap, Amjad Javed, Lucia R. Languino et al. · Molecular and Cellular Biology · 2005 · 312 citations · Full text

Tumor Biology, Sclerostin, Mmp9 Promoter +13

Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts.

Jitesh Pratap, Mario Galindo, Sayyed K. Zaidi et al. · PubMed · 2003 · 303 citations

Sclerostin, Osteogenesis, Cell Proliferation +16

Dlx3 Transcriptional Regulation of Osteoblast Differentiation: Temporal Recruitment of Msx2, Dlx3, and Dlx5 Homeodomain Proteins to Chromatin of the Osteocalcin Gene

Mohammad Q. Hassan, Amjad Javed, María I. Morasso et al. · Molecular and Cellular Biology · 2004 · 283 citations · Full text

Sclerostin, Genetics, Osteogenesis +16